Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs U.S. Sleep Apnea Diagnostics and Therapeutics Markets
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

U.S. Sleep Apnea Diagnostics and Therapeutics Markets

DateOct, 2001
Pages0
Price / format€3353 / Hard Copy
€2976 / Site License
€4106 / Enterprisewide

€2 951 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:

Untapped Patient Population Key to Industry Growth

Sleep apnea is as common a disease as adult diabetes. However, limited public

knowledge of this disorder and treatment options have left the vast majority
of sufferers undiagnosed. Considering the potential patient population, the
possibility for growth within this underserved market is tremendous. As there
is no cure for obstructive sleep apnea (OSA), the dependence on

therapeutic equipment will result in strong product demand by a more
cognizant populace.

This Frost & Sullivan study analyzes the state of the U.S. sleep apnea markets,
including in-depth evaluations of the diagnostic and therapeutic sectors. By
monitoring consumer trends and providing expert forecasts, this research
offers a comprehensive guide to this flourishing field.

Reimbursement Policies Impact Therapeutics Sales

Favorable healthcare insurance reimbursements for nasal and facial interfaces
continue to drive replacement sales within the therapeutics market. In
addition to normal product deterioration, private and government healthcare

providers have positively influence sales by offering reimbursements every
three months for the purchase of new nasal masks.

Despite the costs of frequent replacement, medical insurers are willing to pay
for these devices over a patient’s lifetime rather than risk the noncompliance

expenses related to life-threatening diseases such as congestive heart failure,
says the study’s author.

Educational Campaigns Instrumental for Increased Market Share

While the potential market for OSA therapeutic products is enormous,

participants must take a proactive role in helping patients and physicians
understand this disease and the available treatment options. Although

manufacturers have substantially smaller advertising budgets than pharmaceutical
companies, the impact of their campaigns are just as significant in the effort to
better inform the public, says the analyst.

Combined with the relative lack of awareness for OSA, its symptoms, its
consequences, and its general prevalence within the adult population, direct to

consumer marketing is one method which stands to serve multiple goals,
resulting in increased revenues, states the author.
This Frost & Sullivan research offers a focused analysis of the U.S. sleep apnea
markets, enabling users to fully evaluate the industry’s potential and make
informed investment decisions.

Additional Information

Market Participants
AirSep Corp./Medcare Diagnostics Corp.
Airway Management, Inc.
Bio-logic Systems Corp.
BREAS Medical AB/Vital Signs, Inc.

Cadwell Labs

Collins Medical
Compumedics Ltd.
Fisher & Paykel Healthcare Ltd.
Grass Telefactor/AstroMed, Inc.
Influ-ENT Ltd.

Innomed Technologies
Invacare Corp.
LaMont Medical, Inc.
Medical Industries America, Inc.
Nellcor Puritan Bennett Ltd.
Network Concepts, Inc.
Nicolet Biomedical, Inc.
Nidek Medical Products, Inc.
Nihon Kohden Corp.

ResMed
Respironics, Inc.
RhinoMetrics A/S
SensorMedics Corp.
SleepNet Corp.
Sleep Solutions, Inc.
SleepMed, Inc.

SNAP Laboratories

Stellate Systems
Sunrise Medical Ltd.
Tiara Medical Systems, Inc.

Associated Companies
Baltimore Biomedical, Inc.
Braebon Medical Corp.
Dymedix Corp.
Pro-Tech Services, Inc.

Associations

American Academy Otolaryngology










Table of contents:
 1. Executive Summary
A. Market Overview

1. Introduction
B. Market Engineering Awards

1. Entrepreneurial Award

2. Growth Strategy Award

3. Product Line Strategy Award

4. Market Engineering Leadership Award

2. Sleep Apnea Diagnostic Market
A. Market Forecasts

1. Overview

2. Revenue Forecasts

3. Unit Shipment Forecasts

4. Demand Analysis

5. Competitive Analysis

6. Market Engineering Analysis
B. Market Trends

1. Market Drivers

2. Market Restraints

3. Challenge and Strategic Recommenation

4. Technology Trends

5. Product Analysis
C. Full Polysomnography Segment

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
D. Partial Polysomnography

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
E. Portable Polysomnography

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
F. Other Diagnostic Devices

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends

3. Sleep Apnea Therapeutic Market
A. Market Forecasts

1. Overview

2. Revenue Forecasts

3. Unit Shipment Forecast

4. Demand Analysis

5 Competitive Analysis

6. Market Engineering Analysis
B. Market Trends

1. Market Drivers

2. Market Restraints

3. Technology Trends

4. Product Analysis
C. CPAP Segment

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
D. BiLevel CPAP

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
E. Auto CPAP

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
F. Facial Interfaces

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends

4. Special Section: Sleep Apnea Models
A. Models

1. OSA Prevalence Models

2. Diagnosis Rate Model

3. Saturation Model

List Of Figures

Chapter 2

Total Sleep Apnea Diagnostics Market: Market Segmentation (U.S.), 2000
Total Sleep Apnea Diagnostics Market: Revenue Forecasts (U.S.), 1997-2007
Total Sleep Apnea Diagnostics Market: Percent of Revenues by Product Type (U.S.), 1997-2007
Total Sleep Apnea Diagnostics Market: Unit Shipment Forecasts (U.S.), 1997-2007
Total Sleep Apnea Diagnostics Market: Company Market Share by Revenues (U.S.), 2000
Total Sleep Apnea Diagnostics Market: Competitive Structure (U.S.), 2000
Total Sleep Apnea Diagnostics Market: Market Drivers Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Apnea Diagnostics Market: Market Restraints Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Apnea Diagnostics Market: Products Offered by Major Market Participants (U.S.), 2000
Fixed Polysomnography Market: Revenue Forecasts (U.S.), 1997-2007
Fixed Polysomnography Market: Unit Shipment Forecasts (U.S.), 1997-2007
Portable Polysomnography Market: Revenue Forecasts (U.S.), 1997-2007
Portable Polysomnography Market: Unit Shipment Forecasts (U.S.), 1997-2007
Ambulatory Polysomnography Market: Revenue Forecasts (U.S.), 1997-2007
Ambulatory Polysomnography Market: Unit Shipment Forecasts (U.S.), 1997-2007
Partial Channel Devices Market: Revenue Forecasts (U.S.), 1997-2007
Partial Channel Devices Market: Unit Shipment Forecasts (U.S.), 1997-2007

Chapter 3

Total Sleep Apnea Therapeutics Market: Revenue Forecasts (U.S), 1997-2007
Total Sleep Apnea Therapeutics Market: Percent of Revenues by Product Type (U.S.), 1997-2007
Total Sleep Therapeutics Market: Unit Shipment Forecasts (U.S.), 1997-2007
Total Sleep Therapeutics Market: Competitive Structure (U.S.), 2000
Total Sleep Apnea Therapeutics Market: Company Market Share by Revenues (U.S.), 2000
Total Sleep Apnea Therapeutics Market: Market Drivers Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Apnea Therapeutics Market: Market Restraints Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Therapeutics Market: Products Offered by Major Market Participants (U.S.), 2000
CPAP Market: Revenue Forecasts (U.S.), 1997-2007
CPAP Market: Unit Shipment Forecasts (U.S.), 1997-2007
Bilevel CPAP Market: Revenue Forecasts (U.S.), 1997-2007
Bilevel CPAP Market: Unit Shipment Forecasts (U.S.), 1997-2007
Auto CPAP Market: Revenue Forecasts (U.S.), 1997-2007
Auto CPAP Market: Unit Shipment Forecasts (U.S.), 1997-2007
Facial Interfaces Market: Revenue Forecasts (U.S.), 1997-2007
Facial Interfaces Market: Unit Shipment Forecasts (U.S.), 1997-2007

Chapter 4

OSA Prevalence Model A - Calculation, 2000
OSA Prevalence Model: Model A - 9 % General Prevalence (U.S.), 2000-2010
OSA Prevalence Model: Model B - 4% General Male Prevalence, 2% General Female Prevalence (U.S.), 2000-2010
OSA Prevalence Model: Model C - 4% Adult Male Prevalence, 2% Adult Female Prevalence (U.S.), 2000-2010
Diagnosis Rate Model : Sleep Center Model (Model 1) - 2000
Diagnosis Rate Model: Medicare Therapeutics Model (Model 2)- Calculation and Values, 2000
Diagnosis Rate Model: Medicare Diagnosis Model (Model 3)- Calculation and Values, 2000
Market Saturation Model , Model 1: 9 % General Prevalence - 2000 - 2010




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com